The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A recently published study about the failure of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial in the New England Journal of Medicine, argues that the negative outcome of the study was not associated with the non-effectiveness of the product, but the participants deceit and lack of compliance. The VOICE trial was abruptly stopped after independent safety monitors concluded that the women who were given the pills and vaginal gels containing antiretrovirals (ARVs) were becoming infected at the same rate as women who were given a placebo.
The introduction of pre-exposure prophylaxis (PrEP) for people at an increased risk of HIV is challenging healthcare providers. People newly infected with HIV will normally seek care from a doctor specialised in HIV, but for people who protect themselves from HIV through the use of antiretroviral medication (PrEP), they will normally engage with a primary care provider, and not a specialist.